Predictive Value of Elevated White Blood Cell Count in Patients with Preexisting Coronary Heart Disease: The Bezafibrate Infarction Prevention Study

Archives of Internal Medicine

Volumn 164, Issue 4, 2004, Pages 433-439

  Haim, Moti ^a   Boyko, Valentina ^b,c   Goldbourt, Uri ^b,c   Battler, Alexander ^a   Behar, Solomon ^b,c  

^a RABIN MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BEZAFIBRATE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION AND FORECASTING; PRIORITY JOURNAL; SECONDARY PREVENTION;

ANTILIPEMIC AGENTS; BEZAFIBRATE; CORONARY DISEASE; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 1242275178     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.164.4.433     Document Type: Article

References (41)

1. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998;98:731-733.
2. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998;97:425-428.
3. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 1998;97:2007-2011.
4. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001;103:1813-1818.
5. Blankenberg S, Tiret L, Bickel C, et al, for the AtheroGene Investigators. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation. 2002;106:24-30.
6. Brown DW, Giles WH, Croft JBL. Hematocrit and the risk of coronary heart disease mortality; Am Heart J. 2001;142:657-663.
7. Sweetnam PM, Thomas HF, Yarnell JW, Baker IA, Elwood PC. Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies. Am J Epidemiol. 1997;145:416-421.
8. Prentice RL, Szatrowski TP, Fujikura T, Kato H, Mason MW, Hamilton HH. Leukocyte counts and coronary heart disease in a Japanese cohort. Am J Epidemiol. 1982;116:496-509.
9. Gillum RF, Ingram DD, Makuc DML. White blood cell count, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. Am Heart J. 1993;125:855-863.
10. Kannel WB, Anderson K, Wilson PWL. White blood cell count and cardiovascular disease: insights from the Framingham Study. JAMA. 1992;267:1253-1256.
11. Lee CD, Folsom AR, Nieto FJ, et al. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and white men and women: Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2001;154:758-764.
12. Olivares R, Ducimetiere P, Claude JRL. Monocyte count: a risk factor for coronary heart disease? Am J Epidemiol. 1993;137:49-53.
13. Phillips AN, Neaton JD, Cook DG, Grimm RH, Shaper AGL. Leukocyte count and risk of major coronary heart disease events. Am J Epidemiol. 1992;136:59-70.
14. Weijenberg MP, Feskens EJ, Kromhout DL. White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arterioscler Thromb Vasc Biol. 1996;16:499-503.
15. Yarnell JW, Baker IA, Sweetnam PM, et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease: the Caerphilly and Speedwell collaborative heart disease studies. Circulation. 1991;83:836-844.
16. Manttari M, Manninen V, Koskinen P, et al. Leukocytes as a coronary risk factor in a dyslipidemic male population. Am Heart J. 1992;123:873-877.
17. Saito I, Folsom AR, Brancati FL, Duncan BB, Chambless LE, McGovern PGL. Non-traditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Intern Med. 2000;133:81-91.
18. Bovill EG, Bild DE, Heiss G, et al. White blood cell counts in persons aged 65 years or more from the Cardiovascular Health Study: correlations with baseline clinical and demographic characteristics. Am J Epidemiol. 1996;143:1107-1115.
19. Capuano V, Lamaida N, De Martino M, Mazzotta GL. Association between white blood cell count and risk factors of coronary artery disease. G Ital Cardiol. 1995;25:1145-1152.
20. Capuano V, Lamaida N, Mazzotta G, Scotto di Quacquaro GL. Relation between white blood cell count and several risk factors for coronary heart disease in patients with systemic hypertension. G Ital Cardiol. 1998;28:530-535.
21. Facchini F, Hollenbeck CB, Chen YN, Chen YD, Reaven GML. Demonstration of a relationship between white blood cell count, insulin resistance, and several risk factors for coronary heart disease in women. J Intern Med. 1992;232:267-272.
22. Freedman DS, Joesoef MR, Barboriak JJ, Stallone DD, Byers TL. Correlates of leukocyte counts in men. Ann Epidemiol. 1996;6:74-82.
23. Friedman GD, Tekawa I, Grimm RH, Manolio T, Shannon SG, Sidney SL. The leucocyte count: correlates and relationship to coronary risk factors: the CARDIA Study. Int J Epidemiol. 1990;19:889-893.
24. Hansen LK, Grimm RH Jr, Neaton JDL. The relationship of white blood cell count to other cardiovascular risk factors. Int J Epidemiol. 1990;19:881-888.
25. Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ. 2000;321:199-204.
26. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 1997;96:1102-1108.
27. Amaro A, Gonzalez-Juanatey JR, Iglesias C, et al. Leukocyte count as a predictor of the severity of ischaemic heart disease as evaluated by coronary angiography. Rev Port Cardiol. 1993;12:913-917.
28. Held C, Hjemdahl P, Hakan Wallen N, et al. Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris: results from the APSIS study: the Angina Prognosis Study in Stockholm. Atherosclerosis. 2000;148:179-188.
29. Ikata J, Wakatsuki T, Oishi Y, Oki T, Ito SL. Leukocyte counts and concentrations of soluble adhesion molecules as predictors of coronary atherosclerosis. Coron Artery Dis. 2000;11:445-449.
30. Bickel C, Rupprecht HJ, Blankenberg S, et al. Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease. Am J Cardiol. 2002;89:901-908.
31. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study. Circulation. 2000;102:21-27.
32. Brown DW, Giles WH, Croft JBL. White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol. 2001;54:316-322.
33. Danesh J, Collins R, Appleby P, Peto RL. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998;279:1477-1482.
34. Haim M, Benderly M, Brunner D, et al. Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: the Bezafibrate Infarction Prevention (BIP) Registry. Circulation. 1999;100:475-482.
35. Tanne D, Koren-Morag N, Graff E, Goldbourt U. Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry: high triglycerides constitute an independent risk factor Circulation. 2001;104:2892-2897.
36. Tanne D, Benderly M, Goldbourt U, et al. A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the Bezafibrate Infarction Prevention Study. Am J Med. 2001;111:457-463.
37. Benderly M, Graff E, Reicher-Reiss H, Behar S, Brunner D, Goldbourt U, Bezafibrate Infarction Prevention (BIP) Study Group. Fibrinogen is a predictor of mortality in coronary heart disease patients. Arterioscler Thromb Vasc Biol. 1996;16:351-356.
38. Folsom AR, Rosamond WD, Shahar E, et al, Atherosclerosis Risk in Communities (ARIC) Study Investigators. Prospective study of markers of hemostatic function with risk of ischemic stroke. Circulation. 1999;100:736-742.
39. Rohde LE, Lee RT, Rivero J, et al. Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 1998;18:1765-1770.
40. Haim M, Tanne D, Boyko V, et al. Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease: data from the Bezafibrate Infarction Prevention (BIP) Study. J Am Coll Cardiol. 2002;39:1133-1138.
41. Ridker PM, Rifai N, Pfeffer MA, et al. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation. 1998;98:839-844.